HARVARD BIOSCIENCE INC (HBIO) Form 10-Q Quarterly Reports
HARVARD BIOSCIENCE INC (HBIO) is a publicly traded company on the Nasdaq, categorized under SIC 3826 (Laboratory Analytical Instruments). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: HBIO
CIK: 1123494
Exchange: Nasdaq
SIC 3826: Laboratory Analytical Instruments
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerAnden Utzinger
Audit LocationHartford, Connecticut, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-09-22 | — | SCHEDULE 13G/A Filing | 0001019432-26-000013 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | FORM 10-Q | 0001171843-26-005425 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | FORM 8-K | 0001171843-26-005406 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | FORM 8-K | 0001171843-26-005405 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-09 | 4 Filing | 0001171843-26-004082 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001171843-26-004060 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001171843-26-004058 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001171843-26-004057 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001171843-26-004056 | View SEC Doc Filr Page |
| S-8 | 2026-06-10 | — | FORM S-8 | 0001171843-26-004037 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-06-02 | FORM 8-K | 0001171843-26-003877 | View SEC Doc Filr Page |
| SD | 2026-05-27 | — | FORM SD | 0001171843-26-003718 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001019432-26-000010 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | FORM 10-Q | 0001171843-26-003311 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | FORM 8-K | 0001171843-26-003271 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | FORM 8-K | 0001171843-26-003270 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-21 | — | FORM DEFA14A | 0001171843-26-002623 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-21 | 2026-06-02 | FORM DEF 14A | 0001171843-26-002617 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-20 | 4 Filing | 0001171843-26-002156 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-16 | 4 Filing | 0001171843-26-002155 | View SEC Doc Filr Page |
| 4 | 2026-03-23 | 2026-03-20 | 4 Filing | 0001171843-26-001843 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-03-23 | — | SCHEDULE 13D Filing | 0001171843-26-001839 | View SEC Doc Filr Page |
| 4 | 2026-03-18 | 2026-03-17 | 4 Filing | 0001171843-26-001732 | View SEC Doc Filr Page |
| 4 | 2026-03-18 | 2026-03-16 | 4 Filing | 0001171843-26-001689 | View SEC Doc Filr Page |
| 4 | 2026-03-17 | 2026-03-16 | 4 Filing | 0001171843-26-001645 | View SEC Doc Filr Page |